Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 3 hours agoGlobal vaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and...
How Much You Should Have in Your Savings Accounts, Based On Your Age
GoBankingRates via AOL· 5 hours agoThe amount you should save depends on many different factors, including your income, financial...
Mississippi is the latest state sued by tech group over age verification on websites
Atlanta Journal-Constitution· 7 hours agoJACKSON, Miss. (AP) — A new Mississippi law requiring users of websites and other digital services...
The Miss Alabama Controversy, Explained
Snopes via Yahoo News· 3 hours agoForget everything you thought you knew about pageantry. This wasn't the first time Milliken competed in a NAM pageant. She competed before in the Jr Teen...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 4 hours agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
AZ Governor Katie Hobbs accused in alleged 'pay-for-play' scheme involving group home operator
FOX 10 Phoenix· 2 hours agoThe Arizona Attorney General's Office is investigating ties between Governor Katie Hobbs and the...
In Silicon Valley, more support for Trump is trickling in. Is it a big threat to Biden?
LA Times via Yahoo News· 1 hour agoAnd while Northern California tech entrepreneurs overwhelmingly support Democratic candidates, a...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via AOL· 4 hours agoFood and Drug Administration approved the expanded use of GSK's respiratory syncytial virus (RSV)...
Back-to-back shark bite incidents cause Florida county to close waters
NBC Universal via AOL· 2 hours agoShores Court area off Seacrest Beach in Walton County. There were two victims in that attack,...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 4 hours agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...